Clinical Trials Logo

Breast Neoplasms clinical trials

View clinical trials related to Breast Neoplasms.

Filter by:

NCT ID: NCT04796363 Completed - Breast Cancer Clinical Trials

US Guided Erector Spinae Plane Block in Breast Cancer Surgery: Analgesia, Spread and Immunomodulation

Start date: November 25, 2020
Phase: N/A
Study type: Interventional

Prospective interventional study

NCT ID: NCT04792346 Completed - Breast Cancer Clinical Trials

Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer

HIPOMAMMLINF
Start date: January 1, 2015
Phase:
Study type: Observational

Post-operative loco-regional (LR) hypofractionated radiotherapy (Hypo-RT) is an attractive approach in locally advanced breast cancer (LABC).

NCT ID: NCT04789668 Completed - Metastatic Melanoma Clinical Trials

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

Start date: January 15, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the best dose and effect of pimasertib in combination with bintrafusp alfa in treating patients with cancer that has spread to the brain (brain metastases). Immunotherapy with bintrafusp alfa, a bifunctional fusion protein composed of the monoclonal antibody anti-PD-L1 and TGF-beta, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Pimasertib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving pimasertib and bintrafusp alfa may help to prevent or delay the cancer from progressing (getting worse) and/or coming back.

NCT ID: NCT04785599 Completed - Breast Cancer Clinical Trials

Lymphedema Prevention After Lymph Node Emptying

Start date: October 3, 2011
Phase: N/A
Study type: Interventional

ABSTRACT Object: The impact of morbidity and the deterioration in health-related quality of life for patients with lymphedema after axillary lymph node dissection for breast cancer justify the implementation of prevention programs to decrease the incidence of this chronic condition. The aim was to compare the effectiveness of an experimental prevention program with that of our conventional prevention program. Methods: Clinical randomized trial in two parallel groups over a two-year period. Key words: lymphedema, breast cancer, prevention, rehabilitation

NCT ID: NCT04781712 Completed - Breast Cancer Clinical Trials

Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer

MMHTR
Start date: April 22, 2019
Phase: N/A
Study type: Interventional

This study investigated the feasibility of the novel modular mobile health (mHealth) for personalized rehabilitation and explored the participants' satisfaction and app data during treatment of breast cancer.

NCT ID: NCT04775043 Completed - Breast Cancer Clinical Trials

Study Evaluating Hot Flashes in Hormone Sensitive Breast Cancer

HOTSHOT
Start date: March 23, 2021
Phase:
Study type: Observational

The validation of the HFRDIS questionnaire in French will allow the use in common practice of this questionnaire in consultation in order to have a concrete and reproducible assessment of the impact of hot flashes on the daily life of patients. This validation will also allow this questionnaire to be used in therapeutic trials to assess the effectiveness of a symptomatic treatment under study. The use of this questionnaire in patients on hormone therapy will allow for an overall assessment of the impact of hot flashes in their daily lives. There are no risks induced by participation in this research, it is only an observational study without change on the monitoring of participants in both cohorts.

NCT ID: NCT04771975 Completed - Breast Cancer Clinical Trials

Connecting Breast Cancer Survivors for Exercise

C4E
Start date: May 10, 2021
Phase: N/A
Study type: Interventional

Phase 1: The purpose of this study is to examine interpersonal and individual effects of partnering BCS with a peer and a qualified exercise professional (QEP) on self-reported exercise volume (MVPA; primary outcome), and device-measured exercise volume (MVPA; Fitbit), social support, and HRQOL (secondary outcomes). Cost-effectiveness and intervention adherence will also be explored as tertiary outcomes. The effects of a peer and QEP-support intervention group, labelled MatchQEP, will be compared to a control group of BCS who are matched with a peer, but not a QEP, labelled Match. Phase 2: The purpose of this study is to examine whether the addition of 8-weekly QEP-lead resistance training Zoom sessions with an exercise partner interacts with social support (i.e., tangible, informational, emotional) and how this interaction relates to overall exercise volume as an extension of Phase 1 (one year after phase 1 was completed). A secondary aim of Phase 2 is to examine the direct influence of resistance training on body image, self-efficacy, the physical self, and body functionality among the participants.

NCT ID: NCT04770129 Completed - Clinical trials for Metastatic Breast Cancer

Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in Turkey

Start date: March 22, 2021
Phase:
Study type: Observational

This study is planned as a secondary data use (SDU) study and the data collection will be performed retrospectively. Patients who presented to the participating sites with metastatic breast cancer will be defined, and patients' data will be recorded into a database.

NCT ID: NCT04767607 Completed - Breast Cancer Clinical Trials

Study of Prediction of Ovarian Reserve in Yong Breast Cancer Patients Treated With Chemotherapy

Start date: June 1, 2020
Phase:
Study type: Observational

The purpose of this study is to predict the ovarian reserve, especially premature ovarian insufficient (POI), in young breast cancer patients during chemotherapy treatment using ultrasensitive anti-Müllerian hormone (AMH) detection method.

NCT ID: NCT04767464 Completed - Breast Cancer Clinical Trials

Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups

CC-V
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The Compass Course (CC) is a group intervention designed for individuals with Breast Cancer. Over the course of 8 face-to-face group sessions, the CC is designed to help participants reclaim a sense of self-grounded purpose in daily life, defined as intentional use of time and energy in ways that align with one's values, strengths, and sources of personal meaning (e.g., inner compass) in the moments that compose a day. Because of COVID-19, in-person groups are discouraged and so we need to identify new ways to provide group-based interventions that are feasible and efficacious.